These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 17653725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [Abstract] [Full Text] [Related]

  • 3. Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.
    Nika M, Blachley TS, Edwards P, Lee PP, Stein JD.
    JAMA Ophthalmol; 2014 Oct; 132(10):1199-208. PubMed ID: 24970348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
    Karkanová M, Matusková V, Vlková E, Dosková H, Uhmannová R.
    Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
    [Abstract] [Full Text] [Related]

  • 6. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS, Severns ML.
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [Abstract] [Full Text] [Related]

  • 7. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK, Yu M, Weleber RG.
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [Abstract] [Full Text] [Related]

  • 8. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF.
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
    Ingster-Moati I, Bui Quoc E, Crochet M, Orssaud C, Dufier JL, Roche O.
    J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Retinal damage by (hydroxy)chloroquine intake: published evidence for an efficient ophthalmological follow-up].
    Pluta JP, Rüther K.
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):891-6. PubMed ID: 19916149
    [Abstract] [Full Text] [Related]

  • 20. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M.
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.